Gao-led consortium makes takeover bid for China Biologic
Note: This section contains information in English only.
Tue, 21 Aug 2018 05:15:02 GMT
Source: Dukascopy Bank SA
On Monday, China Biologic Products received a $3.9B worth all-cash proposal from a consortium, which includes Bank of China Group, CDH Investments and GL Capital Group, led by the firm's former CEO Davd Gao.
For further information regarding potential cooperation, please call us or make callback request.
To learn more about Dukascopy Bank Binary Options
/ Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Business Introducer and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.